NasdaqGS:INDVPharmaceuticals
Is It Too Late To Consider Indivior Pharmaceuticals (INDV) After Its 261% One-Year Surge?
Investors may be wondering if Indivior Pharmaceuticals at US$39.60 is still offering value after its strong run, or if most of the upside is already reflected in the price.
The stock has returned 7.7% over the last week, 30.0% over the last month, 10.8% year to date and 260.7% over the last year. This naturally raises questions about how the risk reward trade off now looks.
Recent news around Indivior Pharmaceuticals has focused on its position in the pharmaceuticals space and how the market...